105 related articles for article (PubMed ID: 15285797)
1. PPARgamma, neuroinflammation, and disease.
Mrak RE; Landreth GE
J Neuroinflammation; 2004 May; 1(1):5. PubMed ID: 15285797
[TBL] [Abstract][Full Text] [Related]
2. Impact and Therapeutic Potential of PPARs in Alzheimer's Disease.
Heneka MT; Reyes-Irisarri E; Hüll M; Kummer MP
Curr Neuropharmacol; 2011 Dec; 9(4):643-50. PubMed ID: 22654722
[TBL] [Abstract][Full Text] [Related]
3. Drug insight: effects mediated by peroxisome proliferator-activated receptor-gamma in CNS disorders.
Heneka MT; Landreth GE; Hüll M
Nat Clin Pract Neurol; 2007 Sep; 3(9):496-504. PubMed ID: 17805244
[TBL] [Abstract][Full Text] [Related]
4. PPARs in the brain.
Heneka MT; Landreth GE
Biochim Biophys Acta; 2007 Aug; 1771(8):1031-45. PubMed ID: 17569578
[TBL] [Abstract][Full Text] [Related]
5. Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice.
Heneka MT; Sastre M; Dumitrescu-Ozimek L; Hanke A; Dewachter I; Kuiperi C; O'Banion K; Klockgether T; Van Leuven F; Landreth GE
Brain; 2005 Jun; 128(Pt 6):1442-53. PubMed ID: 15817521
[TBL] [Abstract][Full Text] [Related]
6. PPARs in Alzheimer's Disease.
Kummer MP; Heneka MT
PPAR Res; 2008; 2008():403896. PubMed ID: 18645613
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation.
Chinetti G; Fruchart JC; Staels B
Inflamm Res; 2000 Oct; 49(10):497-505. PubMed ID: 11089900
[TBL] [Abstract][Full Text] [Related]
8. Review: Peroxisome proliferator-activated receptor gamma and adipose tissue--understanding obesity-related changes in regulation of lipid and glucose metabolism.
Sharma AM; Staels B
J Clin Endocrinol Metab; 2007 Feb; 92(2):386-95. PubMed ID: 17148564
[TBL] [Abstract][Full Text] [Related]
9. Activation of peroxisome proliferator-activated receptor gamma does not explain the antiproliferative activity of the nonsteroidal anti-inflammatory drug indomethacin on human colorectal cancer cells.
Hawcroft G; Gardner SH; Hull MA
J Pharmacol Exp Ther; 2003 May; 305(2):632-7. PubMed ID: 12606626
[TBL] [Abstract][Full Text] [Related]
10. [Protective role of PPARgamma agonists against cardiovascular disease].
Yamagishi S
Nihon Rinsho; 2010 Feb; 68(2):307-11. PubMed ID: 20158101
[TBL] [Abstract][Full Text] [Related]
11. Modulation of PPARgamma activity with pharmaceutical agents: treatment of insulin resistance and atherosclerosis.
Wang M; Tafuri S
J Cell Biochem; 2003 May; 89(1):38-47. PubMed ID: 12682906
[TBL] [Abstract][Full Text] [Related]
12. Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats.
Ko GJ; Kang YS; Han SY; Lee MH; Song HK; Han KH; Kim HK; Han JY; Cha DR
Nephrol Dial Transplant; 2008 Sep; 23(9):2750-60. PubMed ID: 18388116
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic potential of peroxisome proliferator-activated receptor agonists for neurological disease.
Feinstein DL
Diabetes Technol Ther; 2003; 5(1):67-73. PubMed ID: 12725709
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor-gamma agonists inhibit experimental allergic encephalomyelitis by blocking IL-12 production, IL-12 signaling and Th1 differentiation.
Natarajan C; Bright JJ
Genes Immun; 2002 Apr; 3(2):59-70. PubMed ID: 11960303
[TBL] [Abstract][Full Text] [Related]
15. Nonsteroidal anti-inflammatory drugs repress beta-secretase gene promoter activity by the activation of PPARgamma.
Sastre M; Dewachter I; Rossner S; Bogdanovic N; Rosen E; Borghgraef P; Evert BO; Dumitrescu-Ozimek L; Thal DR; Landreth G; Walter J; Klockgether T; van Leuven F; Heneka MT
Proc Natl Acad Sci U S A; 2006 Jan; 103(2):443-8. PubMed ID: 16407166
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications.
Touyz RM; Schiffrin EL
Vascul Pharmacol; 2006 Jul; 45(1):19-28. PubMed ID: 16782410
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells.
Marx N; Duez H; Fruchart JC; Staels B
Circ Res; 2004 May; 94(9):1168-78. PubMed ID: 15142970
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor gamma agonists as therapy for chronic airway inflammation.
Belvisi MG; Hele DJ; Birrell MA
Eur J Pharmacol; 2006 Mar; 533(1-3):101-9. PubMed ID: 16458290
[TBL] [Abstract][Full Text] [Related]
19. Insulin resistance and PPAR insulin sensitizers.
Bhatia V; Viswanathan P
Curr Opin Investig Drugs; 2006 Oct; 7(10):891-7. PubMed ID: 17086933
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor gamma ligands suppress colon carcinogenesis induced by azoxymethane in mice.
Osawa E; Nakajima A; Wada K; Ishimine S; Fujisawa N; Kawamori T; Matsuhashi N; Kadowaki T; Ochiai M; Sekihara H; Nakagama H
Gastroenterology; 2003 Feb; 124(2):361-7. PubMed ID: 12557142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]